• Dyne Therapeutics granted inducement equity awards to 11 newly hired employees under its 2024 Inducement Stock Incentive Plan.
• Awards include non-statutory stock options covering 161,300 shares, priced at the Aug. 19 Nasdaq closing price, with a 10-year term.
• Options vest over four years, starting with 25% on the first anniversary of each employee’s start date.
• Restricted stock units cover 51,200 shares, vesting in four equal annual installments over four years from each start date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608201605PRIMZONEFULLFEED9812925) on August 20, 2026, and is solely responsible for the information contained therein.